Directory
>
Hasane Ratni
Hasane Ratni
Medicinal Chemist | Skyhawk Therapeutics
Switzerland
Hasane Ratni
Summary
Hasane Ratni is a distinguished Vice-President of Chemistry at Skyhawk Therapeutics, renowned for his innovative contributions to drug discovery and development. With a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo, he has a robust academic background that complements his industry experience. He has successfully led the development of six drug candidates into human clinical trials, including Risdiplam, the first approved small molecule targeting RNA. His prolific output includes over 80 patent applications and 35 publications in prestigious journals such as Science and Nature. Recognized with multiple awards, including the Senior Industrial Award from the Swiss Chemical Society, Hasane is a prominent figure in the field of medicinal chemistry. His leadership and expertise have made significant impacts in neuroscience and clinical trials, positioning him as a key player in advancing therapeutic innovations.
Hasane Ratni
Work Experience
Vice-President, Chemistry, Skyhawk Therapeutics at
Skyhawk Therapeutics
May 2022 - Present
Hasane Ratni
Education
University of Geneva, Doctor of Philosophy (Ph.D.), Organic Chemistry
January 1997 - January 2001
École Polytechnique, D.E.A (Master degree) Multinational de chimie moleculaire
Université de Tokyo, Post-doctoral studies
January 2001 - January 2002
Frequently Asked Questions about Hasane Ratni
What is Hasane Ratni email address?
Hasane Ratni's primary email address is ******@skyhawktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Hasane Ratni work for?
Hasane Ratni is a Medicinal Chemist at Skyhawk Therapeutics.
Where Hasane Ratni graduated from?
Hasane Ratni holds a degree in null from University of Geneva.
How can I directly contact Hasane Ratni?
To contact Hasane Ratni directly, you can use the email address ******@skyhawktx.com. Complete contact information is available upon registration with Muraena.
Who is Hasane Ratni?
Hasane Ratni is a distinguished Vice-President of Chemistry at Skyhawk Therapeutics, renowned for his innovative contributions to drug discovery and development. With a Ph.D. in Organic Chemistry from the University of Geneva and post-doctoral studies at the University of Tokyo, he has a robust academic background that complements his industry experience. He has successfully led the development of six drug candidates into human clinical trials, including Risdiplam, the first approved small molecule targeting RNA. His prolific output includes over 80 patent applications and 35 publications in prestigious journals such as Science and Nature. Recognized with multiple awards, including the Senior Industrial Award from the Swiss Chemical Society, Hasane is a prominent figure in the field of medicinal chemistry. His leadership and expertise have made significant impacts in neuroscience and clinical trials, positioning him as a key player in advancing therapeutic innovations.
Hasane`s contact details
******@skyhawktx.com
Colleagues
Senior Research Chemist
Post doctoral scientist
Product Engineer II
Teaching Assistant
Co-Founder; Chairman, Scientific Advisory Board
Research Assistant